With reference to Proposed offer for buyback of up to 1,739,130 fully paid up equity shares of face value of Re 1 each at a price of Rs 575 per fully paid up equity share on a proportionate basis through the tender offer process of the Company, Eris Lifesciences has informed about submission of the Letter of Offer, which is dispatched to its equity shareholders as on July 15, 2019, being the record date for Buyback.
The above information is a part of company’s filings submitted to BSE.